CONTROLLED RELEASE,
SMARTER
CARE

Our clinical projects

We believe our new generation of ‘super generic’ Long Acting Injectables will enable smarter care and reduced costs in the treatment of conditions ranging from hematology/oncology to cardiovascular disorders, psychiatry and many others.

Explore our two projects.

The NEX-18 and NEX-20 project pipeline

Compund Screening

ALD-process develop.

Formulation develop.

Preclinical

Phase I

Phase Ib/II

Phase III

Approval

NEX-18

NEX-20

Our partner pipeline

MTA

Process dev.

In vitro POC

Animal study POC

Clinical POC

Clinical pivotal

Reg. Approval

Astra Zeneca

Partner A-D

Partner E